We are international
Donate
TEXT SIZE   
   back

STEP 9: RELAPSE - DO YOU NEED A CHANGE IN TREATMENT?
REFERENCES
08.18.11

Relapse/Refractory Myeloma Patient: Potential Treatment Guidelines

The use of novel agents in the treatment of relapsed and refractory multiple myeloma

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma

Proteasome inhibitors in the treatment of multiple myeloma

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

  • Leukemia. 2009 Nov;23(11):2147-52. Epub 2009 Jul 23.
    Dimopoulos MA, Chen C, Spencer A, Niesvizky R, Attal M, Stadtmauer EA, Petrucci MT, Yu Z, Olesnyckyj M, Zeldis JB, Knight RD, Weber DM.
    http://www.ncbi.nlm.nih.gov/pubmed/19626046

Lenalidomide plus Dexamethasone for Relapsed Mutiple Myeloma in North America

The Efficacy and Safety of Lenalidomide Plus Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients With Impaired Renal Function


 related articles